Skip to main content
. 2017 Nov 28;16:483. doi: 10.1186/s12936-017-2130-3

Table 4.

Assumptions for the MVDA in addition to those in Tables 2 and 3

Parameter Value Unit
% protective efficacy of RTS,S with 1st dose 75 %
% protective efficacy of RTS,S with 2nd dose 80 %
% protective efficacy of RTS,S with 3rd dose 92 %
Half-life of vaccine protection 90 days

These parameters are from the “Interventions under trial: Focal MVDA (hotspot)” tab in the modelling tool